According to Financial Times, the latest Alphaville piece examines how "compounder" has metastasized from a precise analytical term into a catch-all label. The concept once meant durable businesses with steady reinvestment and predictable long-term returns. Now it's stretched to justify almost any growth stock investors want to own.
Language moves money. Once "compounder" becomes a prestige tag instead of an analytical filter, investors stop asking the hard questions: what rate of growth, for how long, and at what valuation? The result is bad discipline and crowded trades priced for perfection.
The problem isn't compounding itself. It's paying today for a decade of flawless execution, then calling the multiple sensible because the business sounds high quality. Plenty of good companies become bad stocks that way. A weak quarter can't kill the label, but it often kills the multiple.
Markets love words that sound mathematical and feel morally clean. "Compounder" is one of them. It lets managers tell a growth story without sounding speculative, even when the trade is crowded and the assumptions are doing all the work. The confounding 'compounding' of 'compounding' is that the label survives a miss. The valuation often doesn't.
Filed to the Markets desk · 5 days ago